Autolus Therapeutics (AUTL) Revenue (2017 - 2025)
Autolus Therapeutics posted quarterly Revenue of $24.3 million for Q4 2025, up 83655.17% year-on-year from N/an in Q4 2024, and up 14.6% on a QoQ basis from $21.2 million in Q3 2025.
Autolus Therapeutics (AUTL) has 7 years of Revenue data on file, last reported at $24.3 million in Q4 2025.
- For the quarter ending Q4 2025, Revenue rose 83655.17% year-over-year to $24.3 million; the trailing twelve-month figure through Dec 2025 stood at $75.4 million (up 644.28% YoY), and the FY2025 full-year result was $75.4 million, up 644.94% from the prior year.
- Revenue for Q4 2025 stood at $24.3 million, up from $21.2 million in the prior quarter.
- Across five years, Revenue topped out at $24.3 million in Q4 2025 and bottomed at -$1.2 million in Q4 2021.
- The 5-year median for Revenue is $1.3 million (2023), against an average of $6.8 million.
- The widest annual swing landed in 2021, when Revenue tumbled 394.31%; it then soared 83655.17% in 2025.
- A 5-year view of Revenue shows it stood at -$1.2 million in 2021, then surged by 113.96% to $166000.0 in 2022, then soared by 144.58% to $406000.0 in 2023, then plunged by 92.86% to $29000.0 in 2024, then jumped by 83655.17% to $24.3 million in 2025.
- The last three Revenue figures came in at $24.3 million (Q4 2025), $21.2 million (Q3 2025), and $20.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 306.30 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 2.99 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 3.61 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1.17 Bn |
| 10 | Autolus Therapeutics | - | - | -1.04 Mn | 24.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 24.29 Mn |
| Sep 30, 2025 | 21.19 Mn |
| Jun 30, 2025 | 20.92 Mn |
| Mar 31, 2025 | 8.98 Mn |
| Dec 31, 2024 | 29,000.00 |
| Mar 31, 2024 | 10.10 Mn |
| Sep 30, 2023 | 406,000.00 |
| Mar 31, 2023 | 1.29 Mn |
| Mar 31, 2022 | 166,000.00 |
| Dec 31, 2021 | -1.19 Mn |
| Sep 30, 2021 | 236,000.00 |
| Jun 30, 2021 | 1.51 Mn |
| Mar 31, 2021 | 269,000.00 |
| Dec 31, 2020 | 404,000.00 |
| Sep 30, 2020 | 438,000.00 |
| Jun 30, 2020 | 293,000.00 |
| Mar 31, 2020 | 338,000.00 |
| Dec 31, 2017 | 231,000.00 |